Sort
10,766 grants matching “checkpoint inhibitor”
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma
$610,890Sean S Park · Mayo Clinic Rochester · R01 · FY2024 · CA
Radiation and dendritic cell combination to improve immunotherapy response in intrahepatic cholangiocarcinoma
$610,890Sean S Park · Mayo Clinic Rochester · R01 · FY2025 · CA
Bottlebrush polymer prodrugs for targeted delivery of combination therapies and in vivo imaging of pharmacological response
$610,792Jeremiah Allen Johnson · Massachusetts Institute Of Technology · R01 · FY2023 · CA
Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity
$610,783Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2024 · CA
Novel gene delivery to modulate the tumor microenvironment and antigen-specific antitumor immunity
$610,783Shu-Hsia Chen · Methodist Hospital Research Institute · R01 · FY2025 · CA
Pan-Cancer characterization of 3âUTR somatic mutations controlling tumor immune evasion
$610,423Ioannis Vlachos · Beth Israel Deaconess Medical Center · R01 · FY2023 · CA
Development of small molecule selective inhibitors of neuronal nitric oxide synthase (nNOS) for melanoma treatment
$610,415Sun Yang · Chapman University · R01 · FY2025 · CA
Identification of small molecule inhibitors to exonuclease 1 for breast cancer treatment
$609,851Binghui Shen · Beckman Research Institute/City Of Hope · U01 · FY2024 · CA
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$609,743Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Immunogen design and testing
$609,490Barton F Haynes · University Of Pennsylvania · P01 · FY2020 · AI
Radioimmunogenomic Habitat Phenotypes to Predict Efficacy of Neoadjuvant Immunotherapies in Non-Small Cell Lung Cancer
$609,048Jia Wu · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Identification of pathways to mitigate Immune-Related Adverse Events with Cancer Immunotherapy
$608,731Donald Ym Leung · National Jewish Health · U01 · FY2024 · AR
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$608,669Nicholas C Denko · Ohio State University · R01 · FY2024 · CA
The Microbiome and Mucosal Immunity in Cervical Cancer Disparities
$608,613Adam Burgener · Case Western Reserve University · R01 · FY2025 · CA
Biomarkers of Response to Immuno-chemotherapy & oliGometastatic Hypofractionated radioTherapy (BRIGHT) for Lung Cancer: Synergy of PET/CT Imaging and Peripheral Blood Assays
$608,411Stephen R. Bowen · University Of Washington · R01 · FY2025 · CA
Immunogen design and testing
$608,337Barton F Haynes · University Of Pennsylvania · P01 · FY2021 · AI
HIFU-immunotherapy in pancreatic cancer
$608,025Katherine W Ferrara · Stanford University · R01 · FY2023 · CA
SynerGel: A Novel Tumor Microenvironment-Modulating Hydrogel for Local Immunotherapy
$607,926Simon Young · University Of Texas Hlth Sci Ctr Houston · R01 · FY2022 · DE
(PQ6) Mesenchymal stem cell based and immunocompetent mouse models of HIV/AIDS KSHV-driven sarcomagenesis
$607,897Noula Dattu Shembade · University Of Miami School Of Medicine · R01 · FY2024 · CA
Understanding IDH mutant gliomas
$607,784Jing Wu · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$607,771Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Targeting tumor metabolism and immune environment via beta-catenin: Towards precision medicine in HCC
$607,766Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Mechanisms of BET bromodomain metabolic reprogramming in triple negative breast cancer
$607,228Gerald V Denis · Boston University Medical Campus · R01 · FY2022 · CA
A phase I/II study of combined therapy with Th17-inducing dendritic cells and pembrolizumab in patients with recurrent epithelial ovarian cancer
$607,154Keith L Knutson · Mayo Clinic Jacksonville · R01 · FY2024 · CA
Improving Pediatric Melanoma Outcomes in a Longitudinally Evaluated Cohort
$607,140Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA